NewEdge Advisors’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding BCAT
PCM
NewEdge Advisors's BCAT Position: Q1 2026 in Review
NewEdge Advisors increased its BlackRock Capital Allocation Term Trust (BCAT) stake by 4.6% in Q1 2026, buying an estimated $11.5K and bringing the position to 17,638 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #2470.
NewEdge Advisors first reported a position in BCAT in Q2 2025 and has held it in 4 quarters since. 100 funds tracked by Wall St. Rank hold BCAT as of Q1 2026.
- NewEdge Advisors held 17,638 shares of BlackRock Capital Allocation Term Trust worth $249K as of Q1 2026.
- NewEdge Advisors bought 779 BlackRock Capital Allocation Term Trust shares in Q1 2026, an estimated $11.5K.
- BlackRock Capital Allocation Term Trust made up ﹤0.01% of NewEdge Advisors's portfolio in Q1 2026, its #2470 holding.
- NewEdge Advisors first reported a position in BlackRock Capital Allocation Term Trust in Q2 2025 and has held it in 4 quarters since.
- 100 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q1 2026.
Based on NewEdge Advisors's 13F filing for Q1 2026, filed 18 May 2026.